alexa Abstract | Simultaneous HPTLC Determination Of Gliclazide And Rosiglitazone In Tablets

Indian Journal of Pharmaceutical Sciences
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Short Communication Open Access


An HPTLC method has been developed for the simultaneous estimation of gliclazide and rosiglitazone from its combined dosage form. The method involves separation of components by TLC on a precoated silica gel 60 F 254 plate using a mixture of toluene:ethylacetate:methanol (85:5:10) as the mobile phase. Detection of the spot was carried out at 225 nm in absorbance mode. The retardation factors of gliclazide and rosiglitazone were found to be 0.36 and 0.47, respectively. The linearity range was found to be 1-3 μg/10 μI for gliclazide and 0.05-0.1 5 μg/10 μ1 for rosiglitazone.

To read the full article Peer-reviewed Article PDF image

Author(s): S Gayathri A Shantha V Vaidyalingam

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version